Licensed vaccine
IMOVAX RABIES
FDA-licensed vaccine · Sanofi Pasteur · STN 103931
Key facts
| Trade name | IMOVAX RABIES |
|---|---|
| Proper name | Rabies Vaccine |
| Manufacturer | Sanofi Pasteur |
| Submission tracking number (STN) | 103931 |
| Recent FDA documents | April 26, 2024 Approval Letter - IMOVAX RABIES, October 25, 2019 Approval Letter - IMOVAX, Package Insert - IMOVAX RABIES, Supporting Documents older than three years - IMOVAX |
| FDA page updated | Apr 26, 2024 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: